Announcement on Voluntary Disclosure of the Progress in Phase I Clinical Trial for Innovative Drug SGC001 of the Joint-Stock Company

About this update from Beijing Hotgen Biotech Co. Ltd. Class A

Announcement on Voluntary Disclosure of the Progress in Phase I Clinical Trial for Innovative Drug SGC001 of the Joint-Stock CompanyThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Hotgen Biotech Co. Ltd. Class A